| 000 | 01158 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250515164307.0 | ||
| 264 | 0 | _c20090604 | |
| 008 | 200906s 0 0 eng d | ||
| 022 | _a2040-3429 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSuckling, Keith | |
| 245 | 0 | 0 |
_aDrug development research: diabetes favored over cardiovascular disease? _h[electronic resource] |
| 260 |
_bCurrent opinion in investigational drugs (London, England : 2000) _cMar 2009 |
||
| 300 |
_a217-9 p. _bdigital |
||
| 500 | _aPublication Type: Editorial; Introductory Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCardiovascular Agents _xadverse effects |
| 650 | 0 | 4 |
_aClinical Trials as Topic _xtrends |
| 650 | 0 | 4 | _aDrug Approval |
| 650 | 0 | 4 |
_aDrug Discovery _xtrends |
| 650 | 0 | 4 |
_aDrug Industry _xtrends |
| 650 | 0 | 4 |
_aDrugs, Generic _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypoglycemic Agents _xadverse effects |
| 650 | 0 | 4 |
_aMetabolic Syndrome _xdrug therapy |
| 650 | 0 | 4 |
_aResearch Design _xtrends |
| 650 | 0 | 4 | _aTreatment Outcome |
| 773 | 0 |
_tCurrent opinion in investigational drugs (London, England : 2000) _gvol. 10 _gno. 3 _gp. 217-9 |
|
| 999 |
_c18770131 _d18770131 |
||